Cannasouth Trading Update

GENERAL

Tue, Jan 23 2024 03:50 pm

Cannasouth Limited (NZX:CBD), New Zealand’s first and largest listed medicinal cannabis company, is pleased to provide this trading update as the Group commences sales of its own-manufactured CBD oral solutions and dried cannabis flower products.

Group Revenues:
Oct-23 $26,000
Nov-23 $201,000
Dec-23 $243,000

Commercial sales of these products commenced in November 2023 following a lengthy verified process by the Medicinal Cannabis Agency. We are confident with the launch of our new products and expect ongoing revenue growth as clinics and prescribers obtain access to our product range either direct, or via wholesalers.

-ENDS-

For further information visit www.cannasouth.co.nz or contact:

Mark Lucas CEO / Executive Director
Email: [email protected]
Mobile: 021 484 649

Colin Foster
CFO / Company Secretary
Email: [email protected]
Mobile: 027 577 1498